Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04358549 · ClinicalTrials.gov registry record · Phase 2
Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19
A Phase 2 study, sponsored by Fujifilm Pharmaceuticals U.S.A..
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT04358549 is a Phase 2 study that has completed, run by Fujifilm Pharmaceuticals U.S.A.. The registered enrollment target is 50 participants.
The verdict
NCT04358549, a Phase 2 study, has completed, sponsored by Fujifilm Pharmaceuticals U.S.A..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
To determine the effect of favipiravir + SOC v. SOC on COVID-19 viral clearance.
Interventions
- OTHER Standard of Care
- DRUG Favipiravir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-04-17 |
| Est. Completion | 2020-10-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04358549
The ClinicalTrials.gov registry entry for NCT04358549 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujifilm Pharmaceuticals U.S.A., which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04358549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04358549 about?
NCT04358549 is a clinical study titled "Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19". To determine the effect of favipiravir + SOC v. SOC on COVID-19 viral clearance.
What is the current status of trial NCT04358549?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2020-04-17. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04358549?
The interventions under investigation include: Standard of Care (OTHER), Favipiravir (DRUG).
Who is sponsoring clinical trial NCT04358549?
This trial is sponsored by Fujifilm Pharmaceuticals U.S.A., which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.